Novavax, Inc. (NVAX)
9.54
+0.08
(+0.85%)
USD |
NASDAQ |
Feb 25, 16:00
9.56
+0.02
(+0.21%)
After-Hours: 17:51
Novavax Research and Development Expense (Quarterly) : 98.17M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Merck & Co., Inc. | 3.992B |
| Pfizer Inc. | 3.206B |
| Moderna, Inc. | 708.00M |
| Recursion Pharmaceuticals, Inc. | 107.66M |
| Plus Therapeutics, Inc. | 2.436M |